APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $274,130 | -95.0% | 4,156 | -96.1% | 0.00% | -95.0% |
| Q4 2022 | $5,470,091 | -44.1% | 105,784 | -26.2% | 0.02% | -55.6% |
| Q3 2022 | $9,793,000 | +820.4% | 143,385 | +509.5% | 0.04% | +800.0% |
| Q2 2022 | $1,064,000 | -67.2% | 23,525 | -63.2% | 0.01% | -54.5% |
| Q1 2022 | $3,244,000 | +322.4% | 63,852 | +174.0% | 0.01% | +266.7% |
| Q3 2021 | $768,000 | -86.4% | 23,300 | -73.9% | 0.00% | -85.0% |
| Q2 2021 | $5,652,000 | -28.8% | 89,425 | -51.7% | 0.02% | -42.9% |
| Q1 2021 | $7,942,000 | -37.2% | 185,074 | -16.3% | 0.04% | -37.5% |
| Q4 2020 | $12,653,000 | +69.2% | 221,200 | -10.8% | 0.06% | +93.1% |
| Q3 2020 | $7,479,000 | -11.0% | 247,886 | -3.7% | 0.03% | -31.0% |
| Q2 2020 | $8,405,000 | +2322.2% | 257,346 | +1885.4% | 0.04% | +2000.0% |
| Q1 2020 | $347,000 | – | 12,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |